Enlitia has raised capital to fund its international expansion
Enlitia has secured a fundraising round from a local family office in order to fund its international expansion and investment on product development.
Enlitia provides asset performance management and monitoring solutions tailored to the renewable energy sector. Leveraging an advanced AI platform, the company offers real-time insights into the condition and performance of renewable assets, facilitating proactive decision-making and optimization strategies. With a focus on solar and wind energy, Enlitia helps clients navigate energy transition and decarbonization initiatives, driving efficiency and maximizing returns on investment.
Oaklins’ team in Portugal advised the shareholders of Enlitia on the fundraising process.
Sprechen Sie mit dem Deal-Team
Relevante Transaktionen
Niscon Inc. has been acquired by SGPS ShowRig
Niscon Inc. has been successfully acquired by SGPS ShowRig, a global provider of staging, rigging and automation for live entertainment. The acquisition reinforces SGPS Showrig’s commitment to pushing the boundaries of innovation in the entertainment industry. By adding Niscon’s unique motion-control technology to its portfolio, SGPS Showrig strengthens its ability to deliver cutting-edge, precision-driven solutions.
Weitere InformationenFairfest Media has acquired WTE Miami
Fairfest Media, organizer of OTM, the leading travel show in Asia, has acquired WTE Miami, the fastest-growing travel trade show in the USA. The acquisition marks a significant milestone in Fairfest’s global expansion, strengthening its presence in the Americas and beyond by leveraging decades of experience and leadership in Asia and India.
Weitere InformationenBanook, backed by Motion Equity, has acquired Fluidda
Banook Group has acquired Fluidda NV, marking a strategic expansion into advanced in-silico trials and respiratory disease modeling. Combining Banook’s expertise in cardiac safety and clinical data services with Fluidda’s AI-driven respiratory analytics creates a powerful, integrated platform. This deal strengthens Banook’s position in the contract research organization (CRO) sector, offering pharmaceutical clients broader, technology-enabled solutions to drive drug development and reduce costs.
Weitere Informationen